The same fully implanted, wireless device supporting motor recovery after stroke now enables thought-controlled computer use without additional surgery or hardware. Freiburg, Germany, April 29, 2026 – CorTec GmbH today announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled a computer […]
Freiburg, Germany, April 23, 2026 – CorTec GmbH today announced that the U.S. Food and Drug Administration (FDA) has accepted the company into its Total Product Life Cycle Advisory Program (TAP), recognizing the Brain Interchange™ BCI system as a priority innovation in stroke motor rehabilitation. The TAP enrollment follows the recently granted FDA Breakthrough Device
Second implantation at Harborview Medical Center in Seattle marks continued progress in the FDA-approved study informed by promising results from the first participant. Freiburg, Germany, February 10, 2026 – CorTec GmbH, a pioneer in active implantable medical technologies, today announced the successful second implantation of its proprietary BrainComputer Interface (BCI) system, the Brain Interchange™, in
Looking back, 2025 has been a truly remarkable year for CorTec, filled with milestones, inspiring collaborations, and unforgettable moments. Early in the year, we entered into a strategic partnership with Heraeus Medevio. Together combine our strengths in development, prototyping, small series production and large series production. This way both companies create scalable, high-quality solutions,
The closed-loop BCI system, developed entirely in Germany, is currently being evaluated in an FDA-approved clinical trial with stroke patients at Harborview Medical Center in Seattle, a part of UW Medicine Freiburg, Germany, July 29, 2025 – CorTec GmbH, a pioneer in active implantable medical technologies, today announced the first human implantation of its
We’re happy to help you realize your next project. Whether it is a complete implantable system design, an electrode or another component.
Please fill out the form below and our sales team will be in contact with you shortly.
FEATURE
Recording channels
Sampling rate
Sampling dynamic range
High pass filter cut-off
Low pass filter cut-off
Amplifier band pass gain
Band pass roll-off
Reference
Stimulation
Stimulation channels
Current
Current source
Pulse width
Power supply
Wireless data transmission
Closed Loop latency
VALUE
32
1 kHz
16 bit (74 nV smallest increment)
ca. 2 Hz
325 Hz
Adjustable: 100-750
20 dB/dec
Any (subset) of the recording channels selectable by software or one dedicated hard-wired additional contact
Current-controlled, biphasic, rectangular, asymmetric stimulus pulses (cathodic amplitude with pulse width followed by an anodic counter pulse of 1/4x amplitude and 4x pulse width)
32
Max. -6 mA / +1.5 mA (24 µA increments) within
compliance voltage range of -11 V to +5 V
Can be directed to any of the 32 electrode contacts
Negative phase: 10 µs – 2,500 µs
Wireless inductive, 120-140 kHz
Bi-directional, radio frequency in 2400-2483.5 MHz band ≤ 40 ms